Shilpa Gupta discusses two oral abstracts from #ASCO2023 on the CONTACT-03 trial and the EV-103 trial in the latest episode from The Uromigos. Listen now: buff.ly/43vHu7o

#ASCO2023
Proud to present PACHA trial on behalf DIANE GOERE David Malka Ducreux Michel and other investigators 🙏

🔎 Postop HAI vs IV Ox after resection of ≥ 4 CRLM

✅ HAI ↗️ hepatic RFS
📌 Trend to increase DFS and OS
⚠️ higher but manageable Tox

❗️HAI Ox don’t need pump⛽️

#ASCO2023 #ASCO23 Superspreader…

🚨TTF: A new modality for mNSCLC?
🌖Phase III Lunar Study
#ASCO2023 Lung Ca Oral Abstract
🫁TTF + SOC v SOC for mNSCLC after POD on platinum
⭐️3 mo median OS ⬆️ w TTF + SOC vs SOC
⭐️8 mo median OS ⬆️ w TTF + ICI vs SOC
⚠️~50% unknown PD-L1 TPS
⚠️1L tx used no longer SOC

Our very own Dr. Raquibul Hannan at #ASCO2023 discussing the incorporation of SABR into the treatment paradigm of oligometastatic RCC UT Southwestern News UTSW Radiation Oncology UTSW Hematology & Oncology Tian Zhang, MD, MHS

It was awesome to have the opportunity to share so many moments with this amazing #sarcoma experts 🤩☺️ #ASCO2023 Jon Trent, MD, PhD Roberta Sanfilippo Gina Z. D'Amato, MD. Priscila Barreto Coelho, MD

Caught in a Perfect Storm of Clusterfuckery No one could have foreseen this.

Kekoa Taparra, MD, PhD ASTRO Thanks for reporting this & testing post-meeting

Based on the CDC Epidemic Intelligence Service conference, one can expect there are 3,499 just like you who got COVID at #ASCO2023 .

See if you can get Paxlovid & Metformin to minimize your long-COVID risk.
twitter.com/AltenbergLee/s…

🌟 #ASCO2023 : Efficacy of #Sacituzumab Govitecan in Locally Advanced or Metastatic #UrothelialCancer by Trophoblast Cell Surface Antigen 2 (Trop-2) Expression🌟 by Scott Tagawa
ASCO OncoAlert #bladdercancer Bladder Cancer
urotoday.com/conference-hig…

Great time to discuss the topics of posters and make friends! Wating for your result! #ASCO2023

The emerging field of oncolytic virus-based cancer immunotherapy

Cell Press #ASCO23 #ASCO2023 #cancer #Immunotherapy

cell.com/trends/cancer/…

how to search for research in specific disease types

Vivek Subbiah, MD #ASCO23 #ASCO2023

Great pleasure and honor presenting this work at #ASCO2023 . Oncologic outcomes for different axillary staging techniques in node positive #breastcancer undergoing neoadjuvant chemo. A joint work of Universitätsklinikum Heidelberg and Klinische Landesregisterstelle Baden-Württemberg

Transform collaboration, training, and visualization with immersive enterprise AR solutions. Break through physical barriers to boost productivity and drive innovation with AR technology.

As I wrap up my first international conference, I am glad for the opportunity to meet such incredible trailblazers in the area. #ASCO2023 #MedTwitter

SDOH associated with long-term neurocognitive, psychological, QOL outcomes in childhood ca survivors (report from the CCSS dataset). Receiving #MTX & CNS RT exacerbated the adverse impact of SDOH on PROs. #sdoh #ASCO2023 #CCSS #5yearjourney #persistence Emory Office of Nursing Research Winship Cancer Institute of Emory University

Bishal Gyawali ASCO ecancer Common Sense in Oncology Thank you for these excellent and sobering comments of results from #ASCO2023 !

Sorry, the lattes are all gone. If you didn’t get a chance to stop by and see us at #ASCO2023 , no worries. You can catch up on all you missed by going to our website to learn more about our pipeline and the selectivity of rivoceranib. hubs.li/Q01RP9BQ0

😌 Caught in a Perfect Storm of Clusterfuckery Is there any reason this conference won't infect 10% of the conferees as did at the CDC Epidemic Intelligence Service conference?

Are there any fundamental epidemiological, immunological or physical differences to distinguish them?

No?—Expect 3,500 returning oncologists w/COVID

Reduction of adjuvant abemaciclib dose doesn’t seem to affect efficacy in early #breastcancer
#VisualAbstract #ASCO2023

Number 21 is crazy!! 😱👇

Overjoyed to have attended #ASCO2023 ! Our poster on multiple myeloma in young patients aimed to bridge the knowledge gap in this rare condition. 🌟 Gratitude to ASCO for driving progress in the field of Hem/Onc. Cleveland Clinic Florida Chakra Chaulagain MD FACP Barbara Dominguez #MultipleMyeloma

Thank you to the ASCO selection committee for the honor of chairing the Education session on Oligometastatic RCC! Glad to have caught up with many friends at #ASCO2023 Sumanta K. Pal, MD, FASCO Nazli Dizman Mark Stein Petros Grivas Tian Zhang, MD, MHS Jessica Hawley MD MS Kristine Lacuna, MD Hiba Khan MD MPH

CINV POD STUDY #ASCO2023
meetings.asco.org/abstracts-pres…

Ainhoa Madariaga ASCO GYN Cancer | #GYNCSM GEICO-Spanish Gynaecological Cancer Research Group Rodrigo Sánchez-Bayona Lawrence Kasherman luigimanso Pablo Tolosa Ortega Eva M Ciruelos JOSE MANUEL ESTRADA World Ovarian Cancer Coalition Well done Ainhoa!! Great Work & Team gathering #ASCO2023